Özlem Türeci
Founder at BIONTECH SE
Net worth: 84 M $ as of 2024-03-30
Özlem Türeci active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BIONTECH SE | Chief Tech/Sci/R&D Officer | 2017-12-31 | - |
| Founder | 2008-06-01 | - | |
| Association For Cancer Immunotherapy | President | - | - |
| Director/Board Member | - | - | |
| Ci3 Management UG | Chairman | - | - |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Corporate Officer/Principal | - | - |
Career history of Özlem Türeci
Former positions of Özlem Türeci
| Companies | Position | Start | End |
|---|---|---|---|
Ganymed Pharmaceuticals AG
 Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Chief Executive Officer | 2007-12-31 | - |
| Chief Tech/Sci/R&D Officer | 2000-12-31 | - | |
| Founder | 2000-12-31 | - |
Training of Özlem Türeci
| Universität des Saarlandes | Undergraduate Degree |
Statistics
International
| Germany | 7 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BIONTECH SE | Health Technology |
| Private companies | 4 |
|---|---|
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Health Services |
| Association For Cancer Immunotherapy | |
| Ci3 Management UG |
- Stock Market
- Insiders
- Özlem Türeci
- Experience